NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.
about
Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritisExtending the translational potential of targeting NO/cGMP-regulated pathways in the CVSSingle oral dose study of two isosorbide-based aspirin prodrugs in the dogVasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti-inflammatory drugsNCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytesPharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersRole of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferationTherapeutic effects of nitric oxide-aspirin hybrid drugsNitroparacetamol exhibits anti-inflammatory and anti-nociceptive activitySilencer of death domains controls cell death through tumour necrosis factor-receptor 1 and caspase-10 in acute lymphoblastic leukemiaSynthesis and hydrolytic behaviour of glycerol-1,2-diibuprofenate-3-nitrate, a putative pro-drug of ibuprofen and glycerol-1-nitrate.Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic miceEffects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.Nitric oxide donor drugs: current status and future trends.GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.Inhibitory effect of NO-releasing ciprofloxacin (NCX 976) on Mycobacterium tuberculosis survivalNitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells.Recent developments in nitric oxide donor drugs.Endothelial cell dysfunction: can't live with it, how to live without it.NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals.NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.Nitroparacetamol (NCX-701) and pain: first in a series of novel analgesics.The classical vs nonclassical NSAIDs: can the reduction in pain overcome the thrombotic risk?NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?Treatment of osteoarthritis in hypertensive patients.Therapeutic potential of new hydrogen sulfide-releasing hybrids.Nitric oxide modulators: an emerging class of medicinal agents.HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum.A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin.Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potentialAntinociceptive effects of NCX-701 (nitro-paracetamol) in neuropathic rats: enhancement of antinociception by co-administration with gabapentin.Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.Direct gas measurements indicate that the novel cyclooxygenase inhibitor AZD3582 is an effective nitric oxide donor in vivo.Comparison of the antinociceptive activity of two new NO-releasing derivatives of the NSAID S-ketoprofen in rats.NCX-701 (nitroparacetamol) is an effective antinociceptive agent in rat withdrawal reflexes and wind-up.
P2860
Q21195404-AB7D6B84-A32D-4EC8-9012-C434365FF594Q27021649-F60FA647-A4CF-4D64-8E96-38606A108CC3Q28166016-F1856A61-CEAF-47AF-8E73-BC18E630542AQ28187590-158C09F1-BADE-4344-9150-0E0CA7096BC2Q28190347-D8B345BA-D1FA-48B5-958E-79BEFEF92EF0Q28200449-B0EBA45B-60C8-4212-AC5B-D2506A78D674Q28205767-564A95A0-93BF-49A9-9920-73F852092B9CQ28210282-0210E1CD-7329-4F8D-B168-84C8A489D5B3Q28344534-66904817-6BE2-4C29-B332-160D0FD6C5BAQ28541221-EED5CF86-6675-4C95-BFB2-6105B6DC08D2Q30645794-BC528D12-A576-4F5E-B829-B3D80B5252DAQ34010668-72B7C79A-FE73-4519-B32A-C5AC234EE7C7Q34156437-FD7609E8-C3AD-4F00-A7EE-FCD132C3EAA6Q34500809-7147C9EE-B19B-4847-B841-F402BFB5C29AQ34628644-74391E30-4908-42E8-A8D0-36267655A818Q34754579-69008E7D-FDF5-4DED-B82C-B17F06CD1A58Q35102614-7D22C7DB-0576-4AB8-87E7-CC44E70D259CQ35940349-340FC6B9-B037-44E6-A2C5-325E3D1E389DQ36052815-C5EB504B-6C4C-419D-8826-A682332FFB8AQ36093993-DDEEADD1-C3C1-40E1-9A37-6C01EA5C227EQ36176425-20AED904-3F74-457A-8702-92DB36406D89Q36495493-5B857FF1-201E-44AC-927A-AF650DAF5555Q36882663-5E583E6A-48E3-4051-8F9D-28D88D452625Q36951251-C3B4369E-D20C-4075-BEEC-0F72391539D0Q36953015-EF692552-DE21-44E8-A1C2-808FA5A53193Q37166556-2846B6F6-3F25-477D-A8C7-80804C08DE94Q37182798-29F92B72-E648-424D-B057-0390743A15BEQ37670886-D398FC98-F6A9-4B90-9F88-612371505961Q37960619-9B420B5F-695C-441D-8562-517C0407A25BQ38116861-E4AF5E9A-31B6-4699-9C83-BA168D1DE6A7Q39015233-2EFD000A-3F39-44A8-A3C7-9B6CB8953B2FQ39717253-EDB38BA7-3EBF-4BEC-99BF-1FCBD50713DAQ40599774-8B9FCDAD-D4E1-41AC-88E2-F5998E9E386BQ41947362-68CBCB5D-ED98-4159-A8D1-02F5149B6820Q42159113-5B51A6E0-EFAE-4D50-B412-D58AD752206AQ42577505-95870ED7-71AE-4729-9359-4B0EADA3930CQ42667008-59F08AB5-9869-4A0C-8E4A-49E5BD7EE246Q43261437-66EC615C-72ED-4511-9ABA-F26795F0C1C4Q43262079-DE074BCA-B14B-46AA-BF4C-DDEBCFD90E85Q43263858-DFA997F0-13A3-44E5-B8FB-7B930921A650
P2860
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.
@ast
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.
@en
type
label
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.
@ast
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.
@en
prefLabel
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.
@ast
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.
@en
P1476
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents
@en
P2093
P del Soldato
P304
P356
10.1016/S0165-6147(99)01353-X
P577
1999-08-01T00:00:00Z